Cargando…
Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4
Rhabdomyosarcoma is the most common soft tissue sarcoma affecting children, and the overall cure rate of children with metastatic disease remains below 30%. The CXC chemokine receptor-4 (CXCR4)/stromal cell-derived factor-1 (SDF1) axis has been implicated in the promotion of metastatic potential in...
Autores principales: | Kashima, Kenji, Watanabe, Miho, Sato, Yasuko, Hata, Junichi, Ishii, Nobuya, Aoki, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462355/ https://www.ncbi.nlm.nih.gov/pubmed/25154453 http://dx.doi.org/10.1111/cas.12490 |
Ejemplares similares
-
Discovery and characterization of a neutralizing pan-ELR+CXC chemokine monoclonal antibody
por: Boyles, Jeffrey S., et al.
Publicado: (2020) -
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
por: Korbecki, Jan, et al.
Publicado: (2021) -
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
por: Nagaya, Naoya, et al.
Publicado: (2020) -
The Role of CXC Chemokines in Cardiovascular Diseases
por: Lu, Xiyi, et al.
Publicado: (2022) -
The Role of CXC Chemokines in Cancer Progression
por: Wu, Tiantian, et al.
Publicado: (2022)